Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...

The global water and wastewater treatment market size is expected to be worth over USD 652.30 billion by 2034 and is ...

Experts say issues with US funding could lead to delays in HIV treatment for thousands of Ukrainians already grappling with ...

"For pharmaceutical companies, as well as other health care providers, it is essential to understand how MS treatment in ...

Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Dovetail Genomics, a leading innovator in genomic solutions, today announces the availability of its early access services ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

For example, when he was hospitalized with respiratory distress related to ... “Why don’t we have these insights when we need them? Why aren’t we using data to make personalized cancer treatment ...

A recent survey by the European Union Drugs Agency found that 14% of respondants had used ketamine in the last year.

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...